Musculoskeletal Infection Society Annual Meeting
Musculoskeletal Infection Society Annual Meeting
July 30, 2018
1 min read

Megaprostheses for TKA yielded significant complications among septic patients

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

PHILADELPHIA — Patients undergoing total knee arthroplasty experienced significant complications when a megaprosthesis was used for septic indications, according to results presented at the Musculoskeletal Infection Society Annual Open Scientific Meeting.

Carlos Higuera-Rueda podium shot
Carlos Higuera-Rueda

Carlos Higuera-Rueda, MD, and colleagues classified 143 patients treated with megaprostheses for non-tumor indications between 2008 and 2016 as either septic or aseptic. Researchers measured early outcomes, including 90-day non-surgical and surgical complications, length of stay, discharge disposition, readmissions and reoperations, as well as long-term outcomes of mortality, implant survivorship and functional outcomes, including modified Knee Society scores.

Higuera-Rueda noted patients in the septic cohort were older, had a higher BMI, more previous surgeries and more immunosuppressant disease. He also noted differences in readmission rate, discharge destination and infection between the two groups.

“Almost 30% of cases in the septic cohort had an infection within 90 days,” Higuera-Rueda said in his presentation.

In addition, approximately 33% of patients in the septic cohort underwent revision for infection, he said. Compared with the aseptic cohort, according to Higuera-Rueda, the septic cohort had an almost 400% higher chance of having a revision. He noted they found similar results when it came to mortality.

“When we looked at Kaplan Meier survivorship, aseptic indication had a 76% survivorship at 120 months whereas, the septic indication, only 36% survivorship at 120 months,” Higuera-Rueda said. – by Casey Tingle



Yakubek G, et al. Total knee arthroplasty megaprosthesis in non-tumor patients – Are septic indications worth the effort? Presented at: Musculoskeletal Infection Society Annual Open Scientific Meeting; July 27-28, 2018; Philadelphia.


Disclosure: Higuera-Rueda reports no relevant financial disclosures.